#Health / Well-being #Diagnostics
- Silent phase
- Preventative treatment
- Animal model
As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.Discover >
Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.Discover >
#Health / Well-being #Diagnostics
AgenT is developing an unprecedented blood test to identify patients with Alzheimer’s disease much earlier in disease course than current detection methods are able to do. The company also does drug repositioning research to identify compounds potentially active in the silent phase of Alzheimer’s disease.
The development of AgenT’s exclusive and patented animal model began in 2012. Its inventor, Jérôme Braudeau, PhD in neurosciences, joined forces thereafter with Baptiste Billoir in 2016 to create AgenT in 2018.
DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
The only way to find an effective treatment for Alzheimer’s disease is to concentrate on its silent phase (15 to 20 years before its diagnosis as currently practiced).
That is why AgenT is developing an unprecedented silent-phase blood test and treatments to prevent the development of symptoms
ACCOMPLISHMENTS / COLLABORATIONS / HIGHLIGHTS
AgenT’s animal model, the foundation of its activities, has been described in mice (Audrain et al, 2016) and rats (Audrain et al, 2017). The scientific aspects of the company’s vision were also validated in a 2018 publication (Souchet et al, 2018).
AgenT is actively searching for financial (campaign underway), academic and private partners to advance in the fight against Alzheimer’s disease.
In the same field
CGenetix, is a medTech start-up developing in vitro medical diagnostic devices for the follow-up of transplant patients.Discover
Research & development for an in vitro diagnostic tool for endometriosisDiscover
SafeInsight seeks to provide a response to the growing concerns of consumers for the composition of the products they buy and accompanies manufacturers aiming to attentively circumscribe the problem of endocrine disruptors.Discover
Ciclix is a tech driven company specialized in process digitization for hospitals and focused on creating natural and efficient solutions for a variety of user profiles in the hospital environment.Discover
Echoliv is a MedTech startup that develops solutions based on artificial intelligence and applied to hepatic ultrasound. Our goal is to develop software to assist radiologists and hepatologists.Discover
Floating Genes develops diagnostic tools for use in liquid biopsies via the highly sensitive NGS detection of circulating tumor DNA.Discover
– Characterization of antigen / antibody interactions (epitope / paratope) – Optimization of therapeutic antibodiesDiscover
Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.Discover
Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell DiseaseDiscover
IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.Discover
Bioinformatics service provider (gene expression, splicing, SNP, CNV, epigenetics, data integration).Discover
Design, development and commercialization of medical devices and services for the diagnosis of endometriosis.Discover
Enalees conceives, develops and markets next-generation rapid molecular diagnosis tests for veterinarians, and furthermore screening tests for SARS-CoV-2.Discover